NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 84 filers reported holding NEOS THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $3,000 | 0.0% | 4,100 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | -75.0% | 4,100 | -49.4% | 0.00% | – |
| Q4 2019 | $12,000 | 0.0% | 8,100 | 0.0% | 0.00% | – |
| Q3 2019 | $12,000 | -25.0% | 8,100 | -35.7% | 0.00% | – |
| Q2 2019 | $16,000 | -51.5% | 12,600 | 0.0% | 0.00% | – |
| Q1 2019 | $33,000 | – | 12,600 | +629900.0% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 2 | -99.8% | 0.00% | – |
| Q3 2018 | $5,000 | -70.6% | 1,141 | -56.7% | 0.00% | – |
| Q2 2018 | $17,000 | +325.0% | 2,635 | +418.7% | 0.00% | – |
| Q1 2018 | $4,000 | -55.6% | 508 | -41.1% | 0.00% | – |
| Q4 2017 | $9,000 | -70.0% | 863 | -73.3% | 0.00% | – |
| Q3 2017 | $30,000 | +400.0% | 3,234 | +252.3% | 0.00% | – |
| Q2 2017 | $6,000 | -40.0% | 918 | -34.8% | 0.00% | – |
| Q1 2017 | $10,000 | 0.0% | 1,408 | -20.0% | 0.00% | – |
| Q4 2016 | $10,000 | +100.0% | 1,760 | +134.7% | 0.00% | – |
| Q3 2016 | $5,000 | -28.6% | 750 | 0.0% | 0.00% | – |
| Q2 2016 | $7,000 | -12.5% | 750 | 0.0% | 0.00% | – |
| Q1 2016 | $8,000 | +100.0% | 750 | +275.0% | 0.00% | – |
| Q3 2015 | $4,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|